EDN1 and Hyperglycemia: The macitentan wasstudied in hyperglycemia-induced kidney injury in mouse models of type 2diabetes41, but inasmuch hypertension anddiabetes are major risk factors for chronic kidney disease, our study evaluated theeffect of ET-1 antagonist on renal function of rats simultaneously hypertensive anddiabetic.